|
AFRICA |
PRIMARY DRUG AMONG PERSONS TREATED FOR DRUG PROBLEMS IN AFRICA
2017 (or latest year available)
|
Country/Territory |
Source |
Treatment |
Distribution of main drugs in percentages* |
Treatment |
Data |
|||||||
|
Cannabis |
Opioids |
Cocaine |
ATS |
Tranquillizers |
Hallucinogens |
Solvents and |
Other † |
|||||
|
Algeria |
ARQ |
2017 |
29.7% |
40.6% |
22,444†† |
|||||||
|
Botswana |
ARQ |
2010 |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
228 |
|
|
Burkina Faso |
ARQ |
2008 |
58.8% |
0.0% |
20.6% |
20.6% |
0.0% |
0.0% |
0.0% |
0.0% |
65 |
a,d |
|
Cabo Verde |
ARQ |
2006 |
|
|
|
|
|
|
|
|
57 |
|
|
Central African Republic |
ARQ |
2017 |
63.6% |
0.0% |
0.5% |
0.0% |
35.9% |
0.0% |
0.0% |
0.0% |
1,103 |
|
|
Egypt |
ARQ |
2007 |
50.1% |
42.7% |
0.0% |
7.2% |
0.0% |
0.0% |
0.0% |
0.0% |
129,850 |
a |
|
Eritrea |
ARQ |
2006 |
38.5% |
11.5% |
7.7% |
0.0% |
0.0% |
0.0% |
42.3% |
0.0% |
26 |
a |
|
Eswatini |
SENDU |
2004 |
92.2% |
0.9% |
0.9% |
0.0% |
5.6% |
0.0% |
0.0% |
0.0% |
128 |
|
|
Ethiopia |
ARQ |
2006/2009*** |
18.8% |
18.8% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
62.5% |
781 |
|
|
Ghana |
ARQ |
2008 |
99.1% |
0.1% |
0.8% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
1,066 |
a,d |
|
Kenya |
ARQ |
2014 |
|
|
|
|
|
|
|
|
6,455 |
|
|
Lesotho |
SENDU |
2004 |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
54 |
d |
|
Madagascar |
ARQ |
2017 |
92.7% |
7.3% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
324 |
|
|
Malawi |
SENDU |
2004 |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
796 |
|
|
Mauritius |
ARQ |
2009 |
19.4% |
80.6% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
1,015 |
|
|
Morocco |
ARQ/Gov. |
2017 |
0.0% |
5.1% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
94.9% |
6,690††† |
k |
|
Mozambique |
ARQ |
2015 |
25.4% |
70.6% |
2.9% |
0.2% |
0.1% |
0.1% |
0.7% |
0.0% |
2,895 |
b |
|
Namibia |
ARQ |
2005/2006*** |
2.4% |
2.4% |
24.4% |
9.8% |
61.0% |
0.0% |
0.0% |
0.0% |
238 |
|
|
Niger |
ARQ |
2006 |
69.2% |
0.0% |
0.0% |
30.8% |
0.0% |
0.0% |
0.0% |
0.0% |
168 |
|
|
Nigeria |
ARQ |
2017 |
53.9% |
39.4% |
3.4% |
0.0% |
3.4% |
|
0.0% |
0.0% |
917 |
k |
|
Senegal |
ARQ/Gov. |
2017 |
89.0% |
6.5% |
1.1% |
0.5% |
0.0% |
0.0% |
0.0% |
2.9% |
3,564†††† |
k |
|
Seychelles |
ARQ |
2007 |
55.0% |
45.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
149 |
a,d |
|
Sudan |
ARQ |
2014 |
0.0% |
0.0% |
0.0% |
58.8% |
41.2% |
0.0% |
0.0% |
0.0% |
34 |
|
|
South Africa |
ARQ |
2017 |
35.0% |
17.3% |
3.4% |
15.6% |
4.2% |
0.0% |
0.5% |
|
19,492†† |
b,e,f |
|
United Republic of Tanzania |
ARQ |
2014 |
0.0% |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
1,787 |
i |
|
Togo |
ARQ |
2010 |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
217 |
|
|
Tunisia |
ARQ |
2013 |
|
|
|
|
|
|
|
|
4,000 |
|
|
Zambia |
ARQ |
2017 |
|
|
|
|
|
|
|
40.6% |
3,235 |
b,c,d,e |
Notes
* Definitions of treatment interventions, recording practices (including counting rules) and methods for determining the primary drug of abuse differ from country to country; percentages may fail to add up to 100 per cent owing to incomplete reporting, gaps in identifying primary drug of abuse and treatment for multiple drugs.** Figures may reflect number of persons or treatment episodes depending on the Member State; figures exclude alcohol and nicotine. In cases where the total of the reported values by drug type exceeded the reported value for all treatment, the percentages are expressed as a proportion of the total.
*** If multiple years are given, the second year specified is for the number of people treated (second to last column).
† In addition to miscellaneous and unspecified drugs, the category "Other" includes substances not under international control.
†† Algeria and South Africa:
In these cases there is a big difference between the reported figure for the total number of people in treatment (column ‘Treatment Provided **’) and the sum of the reported figures for each drug group. Information on the nature of this difference is not available.
††† Morocco: Data for 2016 (World Drug Report 2018) represented the total number of people in treatment as of 2016, whereas the current figure refers to the number of people who have entered drug treatment in the year 2017."
†††† Senegal: Data submitted for the category "Other "includes treatment for non-specified substances
Sources
UNODC, Annual Report Questionnaire (ARQ)
Community Epidemiology Network on Drug Use (SENDU)
Government (Gov.)
Data primarily reflect (codes)
- Whole country
- Geographically limited reporting (eg the Capital city)
- Publicly funded treatment
- NGO/ privately funded treatment
- Inpatient/ hospitalization modality
- Outpatient modality
- Limited subpopulation (eg prison, youth, etc)
- Opioid substitution treatment (eg methadone)
- First-time treatment entrants (not returning clients)
- Treatment admissions (not persons)
- Partial coverage (geographical/treatment type)
- Prisons excluded
- Treatment entrants only